Various Procedural Treatment Options for Post-acne Atrophic Scars

Launched by SHEIKH ZAYED MEDICAL COLLEGE · Jan 7, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at different ways to treat scars that some people get after having severe acne. These scars, called atrophic scars, can vary in depth and appearance. The study will compare two treatment methods: one uses microneedling along with a special treatment called platelet-rich plasma (PRP), which comes from the patient’s own blood, while the other uses microneedling with topical insulin. The goal is to find out which method is more effective and safe for reducing these scars.

To participate in this trial, individuals should be between the ages of 13 and 50 and must have atrophic acne scars. They should not have received any other treatments for their scars in the last one to two months. However, pregnant women, those with certain health issues, or anyone with specific skin conditions will not be eligible. Participants can expect to undergo treatments and follow-up assessments to help researchers understand how well each method works. This study is still in the planning phase and is not yet recruiting participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age: 13-50 years
• • Gender: both male and female
• • Type of acne scar: Atrophic acne scar
• • Patients not taking prior treatment in last 1-2 months
• Exclusion Criteria:
• • Pregnancy and lactating females
• • Bleeding disorders
• • Platelet count less than 100000
• • Hypersensitivity to insulin, PRP
• • Keloidal tendency
• • Active herpes simples, warts and molluscum contagiosum
• • Unrealistic expectations